Efficient photooxidation processes for the removal of sildenafil from aqueous environments: A comparative study
Abstract
The erectile dysfunction drug sildenafil has attracted a great deal of attention in recent years due to its widespread legal and illegal use around the world and its increasing use by young people for recreational rather than medical purposes. Due to sildenafil's high stability in various environmental conditions and its accumulation or phototransformation in receiving waters, this dangerous trend poses a significant risk to both human health and the environment. Therefore, in-depth studies are needed to find innovative methods for completely removing sildenafil from the aquatic environment, while limiting the formation of more toxic derivatives. This study investigated the efficacy of photooxidation processes for removing sildenafil and its potentially toxic derivatives from water. Distilled water and synthetic wastewater were treated with three different oxidants: peroxymonosulphate (PMS), peroxide sulphate (PS) and hydrogen peroxide (H2O2), and a heterogeneous catalyst, TiO2. The investigation also considered the formation of potentially toxic phototransformation products, performing a tentative structural identification by LC-ESI-MS and MSn. The results proved that the Sunlight/PMS system is the most effective for entirely and environmentally friendly removal of this drug and its transformation products from aquatic environments, achieving complete degradation in distilled water and synthetic wastewater after 80 and 130 minutes of irradiation, respectively. Toxicity…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.